Eterna Therapeutics Inc. Quarterly Return On Assets in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Eterna Therapeutics Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q2 2024.
  • Eterna Therapeutics Inc. Return On Assets for the quarter ending June 30, 2024 was -48.4 %, a 41.3% increase year-over-year.
  • Eterna Therapeutics Inc. annual Return On Assets for 2023 was -53 %, a 43.1% increase from 2022.
  • Eterna Therapeutics Inc. annual Return On Assets for 2022 was -93.2 %, a 70.3% increase from 2021.
  • Eterna Therapeutics Inc. annual Return On Assets for 2021 was -314 %, a 285% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -48.4 +34.1 +41.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 -46.3 +50.5 +52.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -53 +40.2 +43.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -58.6 +39.2 +40.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -82.6 +238 +74.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -96.8 +168 +63.5% Jan 1, 2023 Mar 31, 2023
Q4 2022 -93.2 +220 +70.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -97.8 +242 +71.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -320 -193 -152% Apr 1, 2022 Jun 30, 2022
Q1 2022 -265 -47 -21.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 -314 -232 -285% Oct 1, 2021 Dec 31, 2021
Q3 2021 -339 -270 -393% Jul 1, 2021 Sep 30, 2021
Q2 2021 -127 -87 -217% Apr 1, 2021 Jun 30, 2021
Q1 2021 -218 -198 -1004% Jan 1, 2021 Mar 31, 2021
Q4 2020 -81.6 -68.2 -509% Oct 1, 2020 Dec 31, 2020
Q3 2020 -68.9 -64.3 -1418% Jul 1, 2020 Sep 30, 2020
Q2 2020 -40.1 -39.3 -4759% Apr 1, 2020 Jun 30, 2020
Q1 2020 -19.8 -18.7 -1818% Jan 1, 2020 Mar 31, 2020
Q4 2019 -13.4 -11.7 -707% Oct 1, 2019 Dec 31, 2019
Q3 2019 -4.54 +1.39 +23.5% Jul 1, 2019 Sep 30, 2019
Q2 2019 -0.83 +7.37 +89.9% Apr 1, 2019 Jun 30, 2019
Q1 2019 -1.03 +7.14 +87.4% Jan 1, 2019 Mar 31, 2019
Q4 2018 -1.66 +4.48 +73% Oct 1, 2018 Dec 31, 2018
Q3 2018 -5.92 -0.82 -16.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 -8.19 -0.54 -7.05% Apr 1, 2018 Jun 30, 2018
Q1 2018 -8.17 +4.24 +34.2% Jan 1, 2018 Mar 31, 2018
Q4 2017 -6.14 +12.6 +67.3% Oct 1, 2017 Dec 31, 2017
Q3 2017 -5.1 +17.2 +77.1% Jul 1, 2017 Sep 30, 2017
Q2 2017 -7.66 +18.4 +70.6% Apr 1, 2017 Jun 30, 2017
Q1 2017 -12.4 +23.3 +65.3% Jan 1, 2017 Mar 31, 2017
Q4 2016 -18.8 +21.9 +53.9% Oct 1, 2016 Dec 31, 2016
Q3 2016 -22.3 +19.1 +46.2% Jul 1, 2016 Sep 30, 2016
Q2 2016 -26 +12.5 +32.4% Apr 1, 2016 Jun 30, 2016
Q1 2016 -35.7 -5.36 -17.7% Jan 1, 2016 Mar 31, 2016
Q4 2015 -40.7 -16.4 -67.6% Oct 1, 2015 Dec 31, 2015
Q3 2015 -41.4 -22.1 -115% Jul 1, 2015 Sep 30, 2015
Q2 2015 -38.5 -22.7 -143% Apr 1, 2015 Jun 30, 2015
Q1 2015 -30.4 -20.5 -207% Jan 1, 2015 Mar 31, 2015
Q4 2014 -24.3 -15.9 -190% Oct 1, 2014 Dec 31, 2014
Q3 2014 -19.3 -18.6 -3031% Jul 1, 2014 Sep 30, 2014
Q2 2014 -15.8 -17.6 -993% Apr 1, 2014 Jun 30, 2014
Q1 2014 -9.87 -7.29 -282% Jan 1, 2014 Mar 31, 2014
Q4 2013 -8.37 -0.52 -6.62% Oct 1, 2013 Dec 31, 2013
Q3 2013 -0.61 +20.8 +97.1% Jul 1, 2013 Sep 30, 2013
Q2 2013 1.77 +30.7 Apr 1, 2013 Jun 30, 2013
Q1 2013 -2.58 +28.8 +91.7% Jan 1, 2013 Mar 31, 2013
Q4 2012 -7.86 Oct 1, 2012 Dec 31, 2012
Q3 2012 -21.5 Jul 1, 2012 Sep 30, 2012
Q2 2012 -28.9 Apr 1, 2012 Jun 30, 2012
Q1 2012 -31.4 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.